Tapan Kadia, MD

Tapan Kadia, MD, is a professor in the department of leukemia at The University of Texas MD Anderson Cancer Center.

Articles by Tapan Kadia, MD

Recently Introduced Low-Intensity Options for Older Patients With AML

January 2nd 2023

Tapan Kadia, MD, discusses the recent and upcoming changes in treatment of acute myeloid leukemia for patients who are not candidates for intensive remission induction therapy.

Improving Low-Intensity Therapy for Older Patients With AML

ByTapan Kadia, MD

December 3rd 2022

Tapan Kadia, MD, discusses potential improvements to lower intensity therapy for less fit patients with acute myeloid leukemia.

Tapan Kadia, MD

Articles by Tapan Kadia, MD

Recently Introduced Low-Intensity Options for Older Patients With AML

Improving Low-Intensity Therapy for Older Patients With AML

Latest Updated Articles

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL

Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC

JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update

LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors

Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma